NCT05293184

Brief Summary

The Global Angelman Syndrome Registry is an online patient organisation driven registry to collect information about the natural history of children and adults with Angelman Syndrome. The registry will facilitate 1) recruitment for clinical trials into therapies and interventions to benefit participants with Angelman Syndrome and their families, and 2) advancement of research and best standards of care for Angelman Syndrome. The registry is currently available in English, Spanish, Traditional Chinese, Italian, Polish, Hindi, and Brazilian Portuguese.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
897mo left

Started Sep 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Sep 2016Dec 2099

Study Start

First participant enrolled

September 28, 2016

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 27, 2017

Completed
4.7 years until next milestone

First Posted

Study publicly available on registry

March 24, 2022

Completed
77.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2099

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2099

Last Updated

February 23, 2024

Status Verified

February 1, 2024

Enrollment Period

83.3 years

First QC Date

June 27, 2017

Last Update Submit

February 21, 2024

Conditions

Keywords

Angelman SyndromeRegistriesObservational study only

Outcome Measures

Primary Outcomes (1)

  • Gather longitudinal data on individuals living with Angelman Syndrome

    Parent/ caregiver reporting on diagnosis, clinical status, and patient-reported outcomes of individual living with Angelman Syndrome. This will be achieved by inviting parents/ caregivers with additional questionnaire like modules, and tracking changes in their responses over time.

    70 years (lifespan)

Study Arms (1)

Individuals with Angelman Syndrome

Individuals from birth to adulthood with Angelman Syndrome

Other: Observational study only

Interventions

Individuals with Angelman Syndrome

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals with a diagnosis of Angelman Syndrome

You may qualify if:

  • Diagnosis of Angelman Syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queensland University of Technology

Brisbane, Queensland, 4000, Australia

RECRUITING

Related Publications (7)

  • Napier KR, Tones M, Simons C, Heussler H, Hunter AA, Cross M, Bellgard MI. A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry. Orphanet J Rare Dis. 2017 Aug 1;12(1):134. doi: 10.1186/s13023-017-0686-1.

    PMID: 28764722BACKGROUND
  • Tones M, Cross M, Simons C, Napier KR, Hunter A, Bellgard MI, Heussler H. Research protocol: The initiation, design and establishment of the Global Angelman Syndrome Registry. J Intellect Disabil Res. 2018 May;62(5):431-443. doi: 10.1111/jir.12482.

    PMID: 29633452BACKGROUND
  • Tones M, Zeps N, Wyborn Y, Smith A, Barrero RA, Heussler H, Cross M, McGree J, Bellgard M. Does the registry speak your language? A case study of the Global Angelman Syndrome Registry. Orphanet J Rare Dis. 2023 Oct 19;18(1):330. doi: 10.1186/s13023-023-02904-1.

    PMID: 37858180BACKGROUND
  • Roche, L., Tones, M., Williams, M.G. et al. Caregivers Report on the Pathway to a Formal Diagnosis of Angelman Syndrome: A Comparison Across Genetic Etiologies within the Global Angelman Syndrome Registry. Adv Neurodev Disord 5, 193-203 (2021). https://doi.org/10.1007/s41252-021-00195-w

    RESULT
  • Leader G, Whelan S, Chonaill NN, Coyne R, Tones M, Heussler H, Bellgard M, Mannion A. Association between early and current gastro-intestinal symptoms and co-morbidities in children and adolescents with Angelman syndrome. J Intellect Disabil Res. 2022 Nov;66(11):865-879. doi: 10.1111/jir.12975. Epub 2022 Sep 2.

  • Roche, L., Tones, M., Cross, M. et al. An Overview of the Adaptive Behaviour Profile in Young Children with Angelman Syndrome: Insights from the Global Angelman Syndrome Registry. Adv Neurodev Disord 6, 442-455 (2022). https://doi.org/10.1007/s41252-022-00278-2

    RESULT
  • Leader G, Gilligan R, Whelan S, Coyne R, Caher A, White K, Traina I, Muchenje S, Machaka RL, Mannion A. Relationships between challenging behavior and gastrointestinal symptoms, sleep problems, and internalizing and externalizing symptoms in children and adolescents with Angelman syndrome. Res Dev Disabil. 2022 Sep;128:104293. doi: 10.1016/j.ridd.2022.104293. Epub 2022 Jul 4.

MeSH Terms

Conditions

Angelman Syndrome

Condition Hierarchy (Ancestors)

Movement DisordersCentral Nervous System DiseasesNervous System DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, InbornImprinting Disorders

Study Officials

  • Helen (Honey) Heussler, MBBS, FRACP DM

    The University of Queensland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Megan Tones, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
70 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Paediatrics and Child Health

Study Record Dates

First Submitted

June 27, 2017

First Posted

March 24, 2022

Study Start

September 28, 2016

Primary Completion (Estimated)

December 31, 2099

Study Completion (Estimated)

December 31, 2099

Last Updated

February 23, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

All external researchers wishing to recruit registry participants for clinical trials or access data are encouraged to review the information on our website (https://www.angelmanregistry.info/collaborate-with-us/) and contact the data curator (curator@angelmanregistry.info)

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Duration of project.
Access Criteria
External researchers wishing to access registry data or recruit participants must comply with the directions outlined above.
More information

Locations